Bruker introduces advanced diagnostic solutions for clinical microbiology and infection diagnostics labs

USA — Bruker, a leading life science research and diagnostics solutions provider headquartered in the US, has unveiled a range of cutting-edge diagnostic solutions specifically designed for routine clinical microbiology and infection diagnostics laboratories.

These solutions include the next-generation MALDI Biotyper IVD Software, MBT Mycobacteria IVD Kit, MBT HT Filamentous Fungi IVD Module, and LiquidArray Gastrointestinal PCR Assay.

Bruker’s innovative MALDI Biotyper (MBT) platform employs a molecular approach based on proteomic fingerprinting to enable swift identification and classification of bacteria, yeasts, and fungi.

According to the company, the platform delivers rapid and reliable results, thus facilitating timely decision-making for better patient outcomes.

The MALDI Biotyper (MBT) system, offers rapid sample target exchange and can analyze up to 600 samples per hour.

Moreover, this system covers over 4,600 species in the reference library, making it a versatile and reliable tool for microbial identification.

The MBT system now comes equipped with the new IDealTune, which offers fully automated tuning of MALDI-TOF parameters within a sample run, delivering consistent data quality without requiring any user intervention.

Wolfgang Pusch, the President of Bruker’s Microbiology and Infection Diagnostics Division, stated that the company’s new diagnostic solutions, such as IVD workflows, kits, software, and reference libraries for mycobacteria and fungi, are expanding the applications of their established MALDI Biotyper platform.

Pusch also highlighted that the new LiquidArray Gastrointestinal is a next-generation syndromic panel that offers amazing pathogen coverage and is ideal for laboratories that require a broad screening approach to detect most pathogens in one run.

Moreover, Bruker has launched its MBT Compass HT IVD software, which allows high sample throughput for microbial identification, delivering a time-to-result of approximately five minutes for 96 sample spots.

This technology advancement offers laboratories increased efficiency, thus enabling them to process more samples and achieve more reliable results in a shorter time.

Mycobacteria present a significant challenge in microbiology, and obtaining accurate results requires optimized sample preparation protocols.

To address this challenge, Bruker has introduced the MBT Mycobacteria IVD Kit, which offers a dedicated sample preparation method for mycobacteria cultivated in liquid or solid media.

The kit includes an inactivation method that eliminates the need for boiling but facilitates incubation of the mycobacteria at room temperature, with an inactivation reagent.

Additionally, Bruker has launched its new MBT HT Filamentous Fungi IVD Module, which employs the advanced Mycelium Transfer (MyT) sample preparation procedure for fast and accurate microbial identification.

Furthermore, the company has introduced the LiquidArray technology, which uses the high-precision FluoroCycler XT thermocycler for rapid, multiplexed PCR pathogen detection.

This technology enables the simultaneous detection of up to 26 pathogens that cause gastroenteritis, using advanced probe and thermocycling technologies with results-at-a-glance visualization.

The LiquidArray Gastrointestinal test is validated on the GenoXtract fleXT, which provides a fully integrated workflow from sample to result, simplifying the extraction and PCR processes.

For all the latest healthcare industry news from Africa and the World, subscribe to our NEWSLETTER, and YouTube Channel, follow us on Twitter and LinkedIn, and like us on Facebook.